A study of 131iodine labeling of indomethacin, its in vivo biological distribution in Lewis-bearing lung cancer, and its induction of apoptosis in lung cancer

Saudi Medical Journal

Volumn 32, Issue 1, 2011, Pages 15-22

  Cai, Jiu Bo ^a   Zhang, Cai Xia ^a   Luo, Jia Wen ^a   Wang, Dong ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; HISTAMINE; HISTAMINE INDOMETACIN I 131; INDOMETACIN; RADIOPHARMACEUTICAL AGENT; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT; RADIOACTIVE IODINE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG SYNTHESIS; FLOW CYTOMETRY; IN VIVO STUDY; LUNG CANCER; MALE; MOUSE; NONHUMAN; RADIOIMMUNOASSAY; ANIMAL; DRUG EFFECT; DRUG POTENTIATION; LEWIS CARCINOMA; LEWIS RAT; LUNG TUMOR; METABOLISM; RAT; THIN LAYER CHROMATOGRAPHY;

ANIMALS; APOPTOSIS; CARCINOMA, LEWIS LUNG; CHROMATOGRAPHY, THIN LAYER; DRUG SYNERGISM; FLOW CYTOMETRY; HISTAMINE; IODINE RADIOISOTOPES; LUNG NEOPLASMS; MALE; MICE; RATS; RATS, INBRED LEW; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79951978819     PISSN: 03795284     EISSN: 16583175     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. El-Sharouni SY, Kal HB, Battermann JJ, Schramel FM. Sequential versus concurrent chemo-radiotherapy in inoperable stage III non-small cell lung cancer. Anticancer Res 2006; 26 (1B): 495-505.
2. Sjödahl R. Nonsteroidal anti-inflammatory drugs and the gastrointestinal tract. Extent, mode, and dose dependence of anticancer effects. Am J Med 2001; 110 (1A): S66-S69.
3. Tegeder I, Pfeilschifter J, Geisslinger G. Cyclooxygenaseindependent actions of cyclooxygenase inhibitors. FASEB J 2001; 15: 2057-2072.
4. Arber N, Eagle CJ, Spicak J, Rácz I, Dite P, Hajer J, et al. Celecoxib for the prevention of colorectal adenomatous polyps. N Engl J Med 2006; 355: 885-895.
5. Basu GD, Pathangey LB, Tinder TL, Lagioia M, Gendler SJ, Mukherjee P. Cyclooxygenase-2 inhibitor induces apoptosis in breast cancer cells in an in vivo model of spontaneous metastatic breast cancer. Mol Cancer Res 2004; 2: 632-642.
6. Brown JR, DuBois RN. Cyclooxygenase as a target in lung cancer. Clin Cancer Res 2004; 10(12 Pt 2): 4266s-4269s.
7. Richter M, Weiss M, Weinberger I, Fürstenberger G, Marian B. Growth inhibition and induction of apoptosis in colorectal tumor cells by cyclooxygenase inhibitors. Carcinogenesis 2001; 22: 17-25.
8. Dong W, Zhao LM, Zhang CX, Du XM, He XJ. Study on Pharmacokinetics of Indomethacin in Tumor-Bearing and Normal Mice. Chinese Pharmaceutical Journal 2008: 43: 48-50.
9. Zhou LK, Zhang CX. A study on tumor affinity of tritium labeled Indomethacin. Chinese Journal of Nuclear Medicine 2004; 24: 209-211.
10. Al-Jammaz I, Al-Otaibi B, Aboul-Enein H, Amartey JK. Synthesis and biodistribution of 2-[123I]iodomelatonin in normal mice. Appl Radiat Isot 2006; 64: 38-42.
11. Lahorte CM, van de Wiele C, Bacher K, van den Bossche B, Thierens H, van Belle S, et al. Biodistribution and dosimetry study of 123I-rh-annexin V in mice and humans. Nucl Med Commun 2003; 24: 871-880.
12. Wagner HN Jr. 2003 SNM Highlights Lecture: From proof of principle to proof of value. J Nucl Med 2003; 44: 11N-36N.
13. Khanna S, Madan M, Vangoori A, Banerjee R, Thaimattam R, Jafar Sadik Basha SK, et al. Evaluation of glycolamide esters of indomethacin as potential cyclooxygenase-2 (COX-2) inhibitors. Bioorg Med Chem 2006; 14: 4820-4833.
14. Hundsberger H, Verin A, Wiesner C, Pflüger M, Dulebo A, Schütt W, et al. TNF: a moonlighting protein at the interface between cancer and infection. Front Biosci 2008; 13: 5374-5386.
15. Rübe CE, van Valen F, Wilfert F, Palm J, Schuck A, Willich N, et al. Ewing's sarcoma and peripheral primitive neuroectodermal tumor cells produce large quantities of bioactive tumor necrosis factor-α (tnf-α) after radiation exposure International Journal of Radiation Oncology 2003; 56: 1414-1425.
16. Sykiotis GP, Papavassiliou AG. Apoptosis: the suicide solution in cancer treatment and chemoprevention. Expert Opin Investig Drugs 2006; 15: 575-577.